CG (n = 30) | aMCI (n = 33) | naMCI (n = 32) | p value (two-tailed) | |
---|---|---|---|---|
Multiple comparison | ||||
Age (years)a | 69.5 (6.4) | 72.6 (5.5) | 69.8 (5.8) | 0.065 |
Gender (female/male)b | 24/6 | 20/13 | 23/9 | 0.23 |
Education (years)a | 12.9 (4.9) | 9.2 (4.0) | 11.8 (4.3) | 0.018 |
CG × aMCI | ||||
(p = 0.017) | ||||
GDSc | – | 1.5 (1.3) | 1 (1.4) | 0.113 |
GAIc | – | 6.6 (4.3) | 5.1 (4.1) | 0.181 |
Hypertensionb | – | 19 (57 %) | 15 (46 %) | 0.388 |
Diabetes mellitusb | – | 7 (21 %) | 3 (9 %) | 0.186 |
MMSEa | 29.0 (1.0) | 27.6 (1.5) | 27.8 (1.9) | 0.000 |
CG × aMCI and naMCI | ||||
(p <0.003) | ||||
CSF Aβc,d | – | 704 (248) | 918 (430) | 0.044 |
CSF tauc,d | – | 258 (125) | 247 (110) | 0.84 |
CSF p-tauc,d | – | 44 (12) | 43 (14) | 0.97 |
CSF p-tau/Aβ proteind | 0.07 (0.05) | 0.06 (0.04) | 0.13 | |
WMH visual scaleb [24] | 0: 06 (20 %) | 0: 04 (12 %) | 0: 04 (13 %) | 0.525 |
I: 13 (43 %) | I: 16 (49 %) | I: 18 (56 %) | ||
II: 08 (27 %) | II: 09 (27 %) | II: 10 (31 %) | ||
III: 03 (10 %) | III: 04 (12 %) | III: 0 (0 %) |